building an achievable, EXECUTABLE GET-TO-MARKET STRATEGY TO ACCELERATE YOUR medical device  DEVELOPMENT EFFORTS

NAMSA’s cross-functional team of product development strategists provides assistance to clients when and where they need support on their path to product development and commercialization. Our highly knowledgeable and experienced team of strategists is leveraged by Sponsors to provide in-house expertise to streamline costs and speed product development and commercialization objectives.

Many strategic consulting options are available to clients, including consulting on an hourly basis, and in all functional areas of the product development continuum, including, but not limited to:

• Biological Safety and Validation
• Clinical Research
• Medical Writing and Scientific Communications
• Preclinical Testing
• Regulatory
• Reimbursement
• Quality

NAMSA’s Get-to-Market Strategy provides a strategic assessment and summary of required activities pertaining to regulatory, quality, preclinical, clinical research, reimbursement and scientific communications to achieve approval for a specific product and therapeutic area. Our strategic experts are aligned to each client’s therapeutic, regulatory and geographic areas of focus, closely collaborating with all stakeholders to provide a detailed, actionable, achievable Get-to-Market Plan that integrates the key pillars of medical device commercialization pathways. Also addressed within this service offering are critical activities to align key stakeholders in an effort to reduce time and costs to approval and commercialization.

NAMSA’s robust team of global scientific and strategic experts understand how to execute the Get-to-Market Plan to achieve cost-efficient, accelerated outcomes for your intended device requirements and business objectives. Simply put—we equip you with the tools and resources you need for success.

At NAMSA, we uniquely understand that medical device success is often measured by the critical components of cost-to-market and predictable development timelines. However, meeting these success measurements is frequently a challenge for device makers when utilizing the standard approach of engaging with multiple vendors to manage various development phases. Not only does this approach present uncoordinated starts and stops, it leaves device manufacturers susceptible to increased timelines and unplanned budgetary constraints.

NAMSA’s proprietary solution for these challenges is our MRO Program service offering. This approach is designed to offer the full continuum of Contract Research Organization (CRO) services to take your medical device from concept to post-regulatory approval with time savings of up to 30% over industry averages and cost minimization of up to 50%.

Find out how we do it! Watch our MRO video here.